Safety and Efficacy Study to Compare IV CXA 101/Tazobactam and Metronidazole With Meropenem in Complicated Intraabdominal Infections
Clinical trial NCT01147640 · COMPLETED
Trial details
- NCT number
- NCT01147640
- Sponsor
- Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-25
- Primary completion
- 2011-02-20
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.